• Study of Lenvatinib and Pembrolizumab for Patients with Recurrent or Metastatic Head and Neck Cancer After Platinum and Immunotherapy Treatment

    Not recruiting

    2 1 1 1
    Denmark France Norway Portugal Romania Spain
  • Study on the Safety and Effectiveness of ADX-914 for Patients with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study on the Effect of Hyperthermic Intraperitoneal Chemotherapy with Cisplatin for Stage III Ovarian Cancer Patients Undergoing Surgery

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Denmark France Germany Ireland Italy The Netherlands +1
  • Study on the Safety and Effectiveness of Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Germany Italy Poland Spain
  • Study on the Safety and Effects of Tolvaptan for Infants and Young Children with Autosomal Recessive Polycystic Kidney Disease

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Germany Poland Spain
  • Study Comparing 7-Day and 14-Day Treatment with Vancomycin, Linezolid, and Daptomycin for Patients with Uncomplicated Enterococcal Blood Infections

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Spain
  • Study on the Long-term Safety of FLT201 for Patients with Gaucher Disease Type 1

    Not recruiting

    1 1 1
    Investigated diseases:
    Spain
  • Long-Term Safety Study of GT005 for Patients with Geographic Atrophy Due to Age-Related Macular Degeneration Previously Treated in a Gyroscope Study

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Poland Spain
  • Study on the Safety and Effectiveness of Vepdegestrant and PF-07220060 for Adults with ER+/HER2- Advanced or Metastatic Breast Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Belgium France Spain
  • Study on the Effects of EryDex (Dexamethasone Sodium Phosphate) for Children Aged 6-9 with Ataxia Telangiectasia

    Not recruiting

    3 1
    Investigated diseases:
    Belgium Denmark Germany Italy Norway Poland +1

powered by